Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02948257 · ClinicalTrials.gov registry record
VASCADE ANTEGRADE-PVD Post-Market Registry
A clinical trial of Surgical Wound, sponsored by Cardiva Medical.
- Completed
- Registry status
- 52
- Enrollment target
- 5
- Study locations
NCT02948257 is a study of Surgical Wound that has completed, run by Cardiva Medical. The registered enrollment target is 52 participants, below the 92-participant average among 17 other Surgical Wound trials with a reported enrollment target (43% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT02948257, a study of Surgical Wound, has completed, sponsored by Cardiva Medical.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of the registry is to collect procedural outcomes data when the Cardiva VASCADE Vascular Closure System (VCS) is used to seal femoral arterial access sites at the completion of ipsilateral peripheral interventional procedures performed through 5-7F introducer sheaths via an antegrade approach.
Conditions Studied
Interventions
- DEVICE Cardiva Medical VASCADE VCS
Study Locations (5)
Louisiana
- Cardiovascular Institute of the South - Houma
Mississippi
- North MS Medical Center - Tupelo
North Carolina
- Coastal Surgery Specialists - Wilmington
Ohio
- Cleveland Clinic Foundation - Cleveland
Texas
- San Antonio Endovascular and Heart Institute - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2017-01-19 |
| Est. Completion | 2017-09-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02948257
The ClinicalTrials.gov registry entry for NCT02948257 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 17 other Surgical Wound trials with a reported enrollment target (43% lower). The listed sponsor is Cardiva Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which Cardiva Medical VASCADE VCS is the first listed.
NCT02948257 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Louisiana, Mississippi, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02948257 about?
NCT02948257 is a clinical study titled "VASCADE ANTEGRADE-PVD Post-Market Registry". The objective of the registry is to collect procedural outcomes data when the Cardiva VASCADE Vascular Closure System (VCS) is used to seal femoral arterial access sites at the completion of ipsilateral peripheral interventional procedures performed through 5-7F introducer sheaths via an antegrade a...
What is the current status of trial NCT02948257?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2017-01-19. Estimated completion is 2017-09-18.
What conditions does trial NCT02948257 study?
This clinical trial studies the following conditions: Surgical Wound.
What interventions are being tested in trial NCT02948257?
The interventions under investigation include: Cardiva Medical VASCADE VCS (DEVICE).
Who is sponsoring clinical trial NCT02948257?
This trial is sponsored by Cardiva Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02948257 being conducted?
This trial has 5 study locations across Louisiana, Mississippi, North Carolina, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
-
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds
RECRUITING · NA
-
A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
RECRUITING
-
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
RECRUITING
-
Regenn® Therapy System Safety Study
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.